Skip to main content

Editas Medicine, Inc 10-Q for FY2023 Q1

Editas Medicine, Inc. (EDIT)

10-Q 2023-05-05 For: 2023-03-31
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on May 5, 2023, covering the quarter ended March 31, 2023 (FY2023 Q1).

Headline figures

Quarter ended March 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$9.85M
up 45.5% from $6.77M a year earlier
Net loss
$49.04M
compared with a net loss of $50.52M a year earlier
Diluted EPS
-$0.71
compared with -$0.74 a year earlier